Medical Director, Norton Cancer Institute Radiation Oncology Co-Director, Brain Tumor Center
Radiation Oncology
Dr. Aaron C. Spalding, MD
|
|
Give Review
Doctor Aaron C. Spalding, MD works in the field of Radiation Oncology. He went to University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. Aaron Spalding is a published doctor. He has 22 publications published. The most current publication "Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients." He is registered with Medicare and accepts Medicare payments.
Publications
- The Effect of Radiation Timing on Patients With High-Risk Features of Parameningeal Rhabdomyosarcoma: An Analysis of IRS-IV and D9803.
- Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy.
- Tumor histology and location predict deep nuclei toxicity: Implications for late effects from focal brain irradiation.
- Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells.
- Multimodality treatment of a ruptured grade IV posterior fossa arteriovenous malformation in a patient pregnant with twins: case report.
- Ablation of breast Cancer stem cells with radiation.
- Metronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiation.
- Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenografts.
- In vivo bioluminescent imaging of irradiated orthotopic pancreatic Cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targ...
- TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis.
- alpha(5)beta(1) Integrin Ligand PHSRN Induces Invasion and alpha(5) mRNA in Endothelial Cells to Stimulate Angiogenesis.
- Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.
- Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.
- Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.
- Radiation therapy reduces local failure and improves overall survival in sPNET.
- Inhibition of protein kinase Cbeta by enzastaurin enhances radiation cytotoxicity in pancreatic Cancer.
- Percent positive biopsy cores as a prognostic factor for prostate Cancer treated with external beam radiation.
- Using ErbB2-negative status to direct therapy in locally advanced breast Cancer.
- Potential for dose-escalation and reduction of risk in pancreatic Cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.
- New and emerging radiosensitizers and radioprotectors.
- Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Schools
University Of Colorado School Of Medicine
University Of Michigan
St Jude Children39s Research Hospital
Conditions Treated
- Pituitary Gland Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Bronze Direct CACA IN HIX
- Pathway X Ind Direct Access KY
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Choice Care PPO
- Preferred PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
University of Michigan Hospitals and Health Centers -
University of Colorado Denver School of Medicine
Hospital
-
Norton Hospital -
Kosair Children's Hospital
Drug Facts
| NPI NUMBER | 1114983871 | |
| NPPES Provider LastName | SPALDING | |
| NPPES Provider FirstName | AARON | |
| NPPES Provider ZIPCode | 40207 | |
| NPPES Provider State | KY | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 188.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 6.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114983871 |
| Last Name Of The Provider | SPALDING |
| First Name Of The Provider | AARON |
| View All |
Similar Doctors
|
Dr. James B. Eckman Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Baby O. Jose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raghuram S. Modur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neal H. Bhatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. B O. Jose, MD |
|
Dr. Mark S. Cornett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph N. Shaughnessy, MD |
|
|
Dr. Matthew H. Bertke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie K. Gurka, MD
This Doctor is OpenDoctor Recommended.
|